5-MeO-DBT

Add links
Source: Wikipedia, the free encyclopedia.
5-MeO-DBT
Clinical data
Other names5-methoxy DBT; N,N-Dibutyl-5-methoxy-1H-indole-3-ethanamine
Identifiers
  • N-Butyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]butan-1-amine
JSmol)
  • CCCCN(CCCC)CCC1=CNC2=C1C=C(C=C2)OC
  • InChI=1S/C19H30N2O/c1-4-6-11-21(12-7-5-2)13-10-16-15-20-19-9-8-17(22-3)14-18(16)19/h8-9,14-15,20H,4-7,10-13H2,1-3H3
  • Key:WVGCRISHWANOTO-UHFFFAOYSA-N

5-MeO-DBT (5-Methoxy-N,N-dibutyltryptamine, 5-MeO-BET) is a rare

psychoactive substance and was identified in a designer drug sample by a forensic laboratory in Slovenia in March 2021,[1] although only analytical studies have been conducted and no pharmacological data is available.[2][3][4]
It is nevertheless controlled under drug analogue legislation in a number of jurisdictions.

See also

References

  1. ^ "Analytical Report. 5-MeO-DBT" (PDF). Slovenia: Nacionalni Forenzični Laboratorij. 10 March 2021.
  2. PMID 15724162
    .
  3. PMID 16096671
    .
  4. doi:10.1016/j.trac.2010.04.008
    .
Retrieved from "https://en.wikipedia.org/w/index.php?title=5-MeO-DBT&oldid=1182788238"